| 发明名称 |
SUBSTITUIERTE 2-(2,6-DIOXOPIPERIDIN-3-YL)- PHTHALIMIDE UND -1-OXOISOINDOLINE UND VERFAHREN ZUR REDUZIERUNG DES TNF-ALPHA-SPIEGELS |
| 摘要 |
<p>Substituted 2-(2,6-dioxopiperidin-3-yl)phtalimides and l-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF alpha in a mammal. Typical embodiments are 1-oxo-2(2,6-dioxo-3-methylpiperidin-3-yl)-4,5,6,7-tetrafluoroisoindoline and 1,3-dioxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4-aminoisoindoline.</p> |
| 申请公布号 |
AT229521(T) |
申请公布日期 |
2002.12.15 |
| 申请号 |
AT19970936295T |
申请日期 |
1997.07.24 |
| 申请人 |
CELGENE CORPORATION |
发明人 |
MULLER, GEORGE, W.;STIRLING, DAVID, I.;CHEN, ROGER, SHEN-CHU |
| 分类号 |
A61K31/4439;A61K31/445;A61K31/454;A61P1/00;A61P1/04;A61P7/00;A61P9/02;A61P9/04;A61P9/10;A61P17/06;A61P19/00;A61P19/02;A61P29/00;A61P31/06;A61P33/06;A61P35/00;A61P37/02;A61P37/06;A61P43/00;C07D401/04;(IPC1-7):C07D401/04 |
主分类号 |
A61K31/4439 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
